Company & Sponsor Intelligence
McGill University Health Centre/Research Institute of the McGill University Health Centre
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting0
Completed2
Countries1
Therapeutic footprint
adhdpain_neuropathyparkinsons
Indexed studies
NCT02566824Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder
adhd · CanadaPHASE4
adhd · CanadaPHASE4
NCT03111485Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
parkinsons · CanadaPHASE4
parkinsons · CanadaPHASE4
NCT02788851The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
adhd · CanadaNA
adhd · CanadaNA
NCT01573260Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease.
parkinsons · CanadaEARLY_PHASE1
parkinsons · CanadaEARLY_PHASE1
NCT05473338Complex Regional Pain Syndrome (CRPS) and the Gut-bacteria
pain_neuropathy · CanadaUNKNOWN
pain_neuropathy · CanadaUNKNOWN
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →